C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/5377 (2006.01) A61P 3/10 (2006.01) A61P 19/00 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2641900
The present invention relates to a new pharmaceutically acceptable salt, the 2- hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a process for its preparation, pharmaceutical formulations containing said salt and to the use of said active salt in therapy, and particularly to GSK3 related conditions and disorders.
La présente invention concerne un nouveau sel pharmaceutiquement acceptable, le citrate de 2-hydroxy-3-[5-(morpholin-4-ylméthyl)pyridin-2-yl]1H-indole-5-carbonitrile, un procédé de préparation associé, des formulations pharmaceutiques contenant ledit sel ainsi que l'utilisation de ce sel actif en thérapie et, en particulier, dans le traitement de troubles et d'états pathologiques associés à la GSK3.
Berg Anna-Lena
Bhat Ratan
Sebhatu Tesfai
Stahle Erica
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
New citrate salt of an indole derivative and its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New citrate salt of an indole derivative and its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New citrate salt of an indole derivative and its... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1978096